409 related articles for article (PubMed ID: 27802243)
1. The Proteasome Inhibition Model of Parkinson's Disease.
Bentea E; Verbruggen L; Massie A
J Parkinsons Dis; 2017; 7(1):31-63. PubMed ID: 27802243
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
3. Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson's disease.
Lewis FW; Fairooz S; Elson JL; Hubscher-Bruder V; Brandel J; Soundararajan M; Smith D; Dexter DT; Tétard D; Pienaar IS
Arch Toxicol; 2020 Mar; 94(3):813-831. PubMed ID: 32078022
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-proteasome system and Parkinson's disease.
Olanow CW; McNaught KS
Mov Disord; 2006 Nov; 21(11):1806-23. PubMed ID: 16972273
[TBL] [Abstract][Full Text] [Related]
5. Does proteasome [corrected] inhibition decrease or accelerate toxin-induced dopaminergic neurodegeneration?
Setsuie R; Kabuta T; Wada K
J Pharmacol Sci; 2005 Mar; 97(3):457-60. PubMed ID: 15764834
[TBL] [Abstract][Full Text] [Related]
6. Role of iron in UPS impairment model of Parkinson's disease.
Le W
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S158-61. PubMed ID: 24262171
[TBL] [Abstract][Full Text] [Related]
7. Proteasome function and pathological proteins in the pathogenesis of Parkinson's disease.
Nomoto M; Nagai M
J Pharmacol Sci; 2005 Mar; 97(3):455-6. PubMed ID: 15781988
[No Abstract] [Full Text] [Related]
8. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
Ross CA; Pickart CM
Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus type 2 vector-mediated glial cell line-derived neurotrophic factor gene transfer induces neuroprotection and neuroregeneration in a ubiquitin-proteasome system impairment animal model of Parkinson's disease.
Du Y; Zhang X; Tao Q; Chen S; Le W
Neurodegener Dis; 2013; 11(3):113-28. PubMed ID: 22626907
[TBL] [Abstract][Full Text] [Related]
10. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
11. Proteomic Study of a Parkinson's Disease Model of Undifferentiated SH-SY5Y Cells Induced by a Proteasome Inhibitor.
Jiang H; Yu Y; Liu S; Zhu M; Dong X; Wu J; Zhang Z; Zhang M; Zhang Y
Int J Med Sci; 2019; 16(1):84-92. PubMed ID: 30662332
[TBL] [Abstract][Full Text] [Related]
12. L-dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells.
Yoshimoto Y; Nakaso K; Nakashima K
FEBS Lett; 2005 Feb; 579(5):1197-202. PubMed ID: 15710413
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.
Xie W; Li X; Li C; Zhu W; Jankovic J; Le W
J Neurochem; 2010 Oct; 115(1):188-99. PubMed ID: 20649845
[TBL] [Abstract][Full Text] [Related]
14. Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein.
Bentea E; Van der Perren A; Van Liefferinge J; El Arfani A; Albertini G; Demuyser T; Merckx E; Michotte Y; Smolders I; Baekelandt V; Massie A
Front Behav Neurosci; 2015; 9():68. PubMed ID: 25873870
[TBL] [Abstract][Full Text] [Related]
15. Does smoking reduce the risk of Parkinson's disease through stimulation of the ubiquitin-proteasome system?
Chapman MA
Med Hypotheses; 2009 Dec; 73(6):887-91. PubMed ID: 19540050
[TBL] [Abstract][Full Text] [Related]
16. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of pathogenesis of Parkinson's disease.
Shadrina MI; Slominsky PA; Limborska SA
Int Rev Cell Mol Biol; 2010; 281():229-66. PubMed ID: 20460187
[TBL] [Abstract][Full Text] [Related]
18. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
19. A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease.
Cook C; Petrucelli L
Biochim Biophys Acta; 2009 Jul; 1792(7):664-75. PubMed ID: 19419700
[TBL] [Abstract][Full Text] [Related]
20. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
Matsuda N; Tanaka K
J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
